|
1
|
Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases.
|
Endocr Relat Cancer
|
2007
|
2.63
|
|
2
|
Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation.
|
J Clin Endocrinol Metab
|
2006
|
1.05
|
|
3
|
Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib.
|
J Clin Oncol
|
2006
|
0.99
|
|
4
|
Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.
|
Am J Clin Nutr
|
2007
|
0.90
|
|
5
|
Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature.
|
Eur J Endocrinol
|
2005
|
0.89
|
|
6
|
Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk.
|
J Nutr
|
2007
|
0.82
|
|
7
|
Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels.
|
Growth Horm IGF Res
|
2008
|
0.82
|
|
8
|
Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients.
|
Int J Cancer
|
2008
|
0.81
|
|
9
|
Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation.
|
Eur J Endocrinol
|
2007
|
0.81
|
|
10
|
Hypoglycemia in a patient with a big "big"-IGF-II-producing tumor.
|
J Clin Endocrinol Metab
|
2013
|
0.80
|
|
11
|
Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age.
|
J Clin Endocrinol Metab
|
2010
|
0.80
|
|
12
|
The insulin-like growth factor-system in a patient with diffuse large B-cell non-Hodgkin's lymphoma and lactic acidosis.
|
Ann Clin Biochem
|
2013
|
0.80
|
|
13
|
Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk.
|
Nutr Cancer
|
2008
|
0.79
|
|
14
|
Insulin-like growth factor-binding protein-1: serum levels, promoter polymorphism, and associations with components of the metabolic syndrome in short subjects born small for gestational age.
|
J Clin Endocrinol Metab
|
2009
|
0.79
|
|
15
|
Marginal growth increase, altered bone quality and polycystic ovaries in female prepubertal rats after treatment with the aromatase inhibitor exemestane.
|
Horm Res Paediatr
|
2010
|
0.79
|
|
16
|
Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
|
Clin Endocrinol (Oxf)
|
2006
|
0.78
|
|
17
|
Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
|
J Clin Endocrinol Metab
|
2007
|
0.76
|
|
18
|
Impaired body weight and tail length gain and altered bone quality after treatment with the aromatase inhibitor exemestane in male rats.
|
Horm Res Paediatr
|
2010
|
0.76
|
|
19
|
'Big'-insulin-like growth factor-II signaling is an autocrine survival pathway in gastrointestinal stromal tumors.
|
Am J Pathol
|
2012
|
0.76
|
|
20
|
IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance: response to Maddux et al.
|
Diabetes Care
|
2007
|
0.75
|
|
21
|
Efficacy of needle-free administration of recombinant human growth hormone in adults with growth hormone deficiency.
|
Br J Clin Pharmacol
|
2006
|
0.75
|
|
22
|
Expression of osteotropic growth factors and growth hormone receptor in a canine distraction osteogenesis model.
|
J Bone Miner Metab
|
2006
|
0.75
|
|
23
|
No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.75
|
|
24
|
The potential of exosomes in diagnosis and treatment of inborn errors of metabolism.
|
J Inherit Metab Dis
|
2014
|
0.75
|